, Singapore
555 views

Raffles Medical Group earnings per share estimate cut by 8-12% for FY22/24

Maybank Securities Research cited two reasons for its lower estimate.

Raffles Medical Group (RFMD) might see lower earnings per share (EPS) from the financial year 2022 to 2024, based on a forecast from Maybank Securities Research.

In a report, the firm said they cut their FY22-24 EPS estimate by 8% to 12% as they expect lower contributions from the private medical provider’s COVID-19 related services and China hospitals.

“We forecast COVID-19 support activities to taper off sequentially, especially its PCR test revenues as Singapore relaxes testing protocols for VTL travellers,” the analyst said.

On the group’s China hospitals, Maybank said: “China is experiencing sporadic COVID-19 clusters that may impact some of RFMD’s operations there.”

“Management has guided that break-even for its Chongqing hospital is likely to be delayed by a year to 2022, and Shanghai operations could incur EBITDA loss of $10m this year,” the analyst added.

The estimated core EPS for FY22, FY23, and FY24 was $0.041, $0.043, and $0.046, respectively.

Meanwhile, Maybank said RFMD would benefit from the government’s restructuring of the local healthcare system under its proposed 2022 budget, “allowing GPs to play a greater role given the fast-ageing population.”

Related: Raffles Medical Group’s H2 2021 net profit declines 7.2% to $44.88m

Join Singapore Business Review community

Follow the link for more news on

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.